CinCor Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
CinCor Pharma, Inc. has filed 141 SEC EDGAR filings since 27 Aug 2021

SEC filing history

Showing 101-125 of 141 matching filings.

Per page
25
Current page
5
8-K File 001-41201

8-K

Filing date
11 Jan 2022
Reporting date
11 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93228

SC 13G

Filing date
11 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-261738

424B4

Filing date
07 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
07 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-261738

EFFECT filing

Filing date
06 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-262045

S-1MEF

Filing date
06 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .